GGTA1 oncolytic virus
GGTA1 oncolytic virus has been studied in 1 paper since 2026: none in people yet, 1 review; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Mar 17, 2026: “The α-Gal Epitope (Galα1-3Galβ1-4GlcNAc) as Therapeutic Agent in Cancer Immunotherapy, Vaccine Effectiveness Amplification and Injured Tissue Regeneration”.
1 paper studies itUpdated
See all 1 papers on GGTA1 oncolytic virus
Latest
1 paper in 12 monthsInternational Journal of Molecular Sciences
The α-Gal Epitope (Galα1-3Galβ1-4GlcNAc) as Therapeutic Agent in Cancer Immunotherapy, Vaccine Effectiveness Amplification and Injured Tissue Regeneration
ReviewCancer